Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRSS1 | P07477 | 8/20 | 0.44 |
| ▸ | F2 | P00734 | 7/20 | 0.44 |
| ▸ | PRSS2 | P07478 | 7/20 | 0.44 |
| ▸ | PRSS3 | P35030 | 7/20 | 0.44 |
| ▸ | F10 | P00742 | 14/20 | 0.43 |
| ▸ | PLG | P00747 | 3/20 | 0.43 |
| ▸ | PLAT | P00750 | 2/20 | 0.43 |
| ▸ | F7 | P08709 | 2/20 | 0.43 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.40 |
| ▸ | PROC | P04070 | 1/20 | 0.40 |
| ▸ | KLK1 | P06870 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6752228 | 0.92 | F10 (0.42) | PRSS1F2PRSS2PRSS3F10 | |
| SCHEMBL6750772 | 0.92 | F10 (0.44) | PRSS1F2PRSS2PRSS3F10 | |
| SCHEMBL6752503 | 0.85 | F10 (0.48) | PRSS1F2PRSS2PRSS3F10 | |
| SCHEMBL6749917 | 0.85 | F10 (0.40) | PRSS1F2PRSS2PRSS3F10 | |
| SCHEMBL6749865 | 0.80 | F10 (0.51) | PRSS1F2F10 | |
| SCHEMBL6854380 | 0.76 | CARM1 (0.39) | PRSS1F2PRSS2PRSS3F10 | |
| SCHEMBL6565271 | 0.74 | F10 (0.47) | PRSS1F2PRSS2PRSS3F10 | |
| SCHEMBL6752275 | 0.74 | F10 (0.61) | PRSS1F2PRSS2PRSS3F10 | |
| SCHEMBL6752489 | 0.73 | F10 (0.44) | PRSS1F2PRSS2PRSS3F10 | |
| SCHEMBL6749876 | 0.72 | F10 (0.50) | PRSS1F2F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040220411-A1 | Oxalic acid derivatives | MERCK PATENT GMBH (DE) | 2004-11-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040220411-A1 | Oxalic acid derivatives | F11, F2, F12 | PRSS1 685/4885F2 2/4885PRSS2 2331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.